JR, G., JA, G., GD, K., ET, S., AJ, L., CD, H., . . . MD, T. (1998). Maintenance of remission of ulcerative colitis: A comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group. Alimentary pharmacology & therapeutics, 12(12), 1207. https://doi.org/10.1046/j.1365-2036.1998.00427.x
Chicago Style (17th ed.) CitationJR, Green, Gibson JA, Kerr GD, Swarbrick ET, Lobo AJ, Holdsworth CD, Crowe JP, Schofield KJ, and Taylor MD. "Maintenance of Remission of Ulcerative Colitis: A Comparison Between Balsalazide 3 G Daily and Mesalazine 1.2 G Daily over 12 Months. ABACUS Investigator Group." Alimentary Pharmacology & Therapeutics 12, no. 12 (1998): 1207. https://doi.org/10.1046/j.1365-2036.1998.00427.x.
MLA (9th ed.) CitationJR, Green, et al. "Maintenance of Remission of Ulcerative Colitis: A Comparison Between Balsalazide 3 G Daily and Mesalazine 1.2 G Daily over 12 Months. ABACUS Investigator Group." Alimentary Pharmacology & Therapeutics, vol. 12, no. 12, 1998, p. 1207, https://doi.org/10.1046/j.1365-2036.1998.00427.x.